Citations

Clear

167 citation(s) found for "Kita, H".

Eosinophil Peroxidase Staining Enhances the Diagnostic Utility of the Cytosponge in Eosinophilic Esophagitis
Masuda, Mia Y. , Barshow, Suzanne , Garg, Shipra , Putikova, Arina, LeSuer, William E., Alexander, Jeffrey A. , Katzka, David A. , Dellon, Evan S. , Kita, Hirohito , Horsley‐Silva, Jennifer L. , Doyle, Alfred D. , Wright, Benjamin L. , Kita, H , Wright, Benjamin L

Mayo Clinic

Clinical and Translational Gastroenterology | September 22, 2022 | Volume: 13 | Issue: 11 | Pages: e00534

10.14309/ctg.0000000000000534 | PMID 36137185 Get It

INTRODUCTION: We aimed to assess the diagnostic utility of eosinophil peroxidase (EPX) staining on Cytosponge (CS) samples in eosinophilic esophagitis (EoE). METHODS: Esophageal biopsy (BX) samples from adult subjects with EoE were assessed using peak eosinophils per high-power field (eos/hpf), EPX, and the EoE histologic scoring system. EPX staining and eos/hpf were compared (BX vs CS). RESULTS: CS EPX positivity correlated with eos/hpf (CS [ r = 0.82, P < 0.0001]; BX [ r = 0.65, P < 0.0001]) and EoE histologic scoring system (grade [ r = 0.62, P < 0.00001]; stage [ r = 0.61, P < 0.0001]). CS EPX identified subjects with active EoE (area under the curve = 0.86, P < 0.0001). DISCUSSION: The correlation of CS EPX with eosinophilic inflammation and histologic disease severity supports its diagnostic utility in EoE.
White Blood Cells and Chronic Rhinosinusitis: A Mendelian Randomization Study
Pongdee, Thanai , Decker, Paul A. , Kita, Hirohito , Larson, Nicholas B. , Kita, H , Larson, Nicholas B , Bielinski, Suzette J. , Decker, Paul A.

Mayo Clinic

No container title available | September 19, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2066263/v1 Get It

Abstract Background Risk factors for the pathogenesis of chronic rhinosinusitis (CRS) remain largely undetermined, which is likely due to the heterogeneity of the disease. White blood cell counts have been largely unexplored as a risk factor for CRS even though different types of white blood cells are involved in the inflammatory process of CRS. Objective To investigate causal associations between different types of white blood cells on risk of CRS utilizing a Mendelian randomization (MR) analysis. Methods A two-sample MR analysis was performed using respective GWAS summary statistics for the exposure traits (neutrophil count, eosinophil count, basophil count, lymphocyte count, and monocyte count) and outcome trait (CRS). For the exposure traits, the European Bioinformatics Institute database of complete GWAS summary data was used. For the outcome trait, summary statistics for CRS GWAS were obtained from FinnGen. Primary analysis for MR was performed using inverse-variance weighted two-sample MR. Sensitivity analyses included weighted median, MR-Egger, and MR-PRESSO (raw and outlier-corrected). Results Eosinophils were associated with CRS (OR = 1.55 [95%CI 1.38,1.73]; p = 4.3E-14). Eosinophil results were similar across additional MR methods. MR results did not demonstrate significant causal relationships between neutrophils, lymphocytes, monocytes, or basophils with CRS. No significant pleiotropic bias was observed. Conclusions In a two-sample MR analysis, a potential causal link between blood eosinophil counts and CRS has been demonstrated. In addition, causal relationships between blood counts among other white blood cell types and CRS were not found. Further studies involving genetic variation in CRS are needed to corroborate genetic causal effects for CRS.
Detergent exposure induces epithelial barrier dysfunction and eosinophilic inflammation in the esophagus
Doyle, Alfred D. , Masuda, Mia Y. , Pyon, Grace C., Luo, Huijun , Putikova, Arina, LeSuer, William E., Flashner, Samuel , Rank, Matthew A. , Kita, Hirohito , Wright, Benjamin L. , Kita, H , Wright, Benjamin L , Nakagawa, Hiroshi

Mayo Clinic

Allergy | July 28, 2022 | Volume: 78 | Issue: 1 | Pages: 192-201

10.1111/all.15457 | PMID 35899466 Get It

AbstractBackgroundEosinophilic esophagitis (EoE) is a chronic allergic disease associated with type 2 inflammation and epithelial barrier dysfunction. The etiology is unknown, however, genetic heritability studies suggest environmental factors play a key role in pathogenesis. Detergents, such as sodium dodecyl sulfate (SDS), are common ingredients in household products such as dish soap and toothpaste. We hypothesized detergent exposure decreases epithelial barrier function and induces esophageal inflammation.MethodsImmortalized esophageal epithelial cells (EPC2) were cultured in air‐liquid interface (ALI) and exposed to SDS. Barrier function/activity was assessed by transepithelial electrical resistance (TEER), FITC‐dextran flux, and RT‐PCR. Additionally, SDS‐treated mouse esophageal organoids were evaluated for morphology. To investigate the effects of SDS in vivo, mice were treated with 0.5% SDS in drinking water for 14 days. Esophagi were assessed by gross morphology, histopathology, protein expression, and bulk RNA sequencing.ResultsWhen EPC2 cells were exposed to SDS (5 μg/ml) for 96 h, TEER decreased (p = 0.03), and FITC‐dextran flux increased (p = 0.0002). mRNA expression of IL‐33 increased 4.5‐fold (p = 0.02) at 6 h and DSG1 decreased (p < 0.0001) by 72 h. Disrupted epithelial integrity was noted in SDS‐treated esophageal organoids. When mice were exposed to SDS, they showed increased esophageal width, chemokine, and metalloprotease levels. Mice treated with SDS also showed increased IL‐33 protein expression, basal zone hyperplasia, CD4+ cell infiltration, and esophageal eosinophilia. RNA sequencing revealed upregulation of immune response pathway genes.ConclusionExposure to SDS decreases esophageal barrier integrity, stimulates IL‐33 production, and promotes epithelial hyperplasia and tissue eosinophilia. Detergents may be a key environmental trigger in EoE pathogenesis.
Physiological microbial exposure has a temporally limited inhibitory effect on lung ILC2 responses to allergens in mice
Block, Katharine E. , Iijima, Koji, Pierson, Mark , Walsh, Daniel, Tei, Rinna, Kucaba, Tamara A., Xu, Julie , Kita, Hirohito , Kita, H , Jameson, Stephen C. , Griffith, Thomas S. , McSorley, Henry J.

Mayo Clinic

No container title available | December 17, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1139168/v1 Get It

Abstract The impact of microbes on restraining the immune response to allergens has been extensively studied and is a key element of the hygiene hypothesis. Lung type 2 innate lymphoid cell responses to airway allergens can be inhibited by administration of a number of microbial products; however, it is unclear whether such an effect would be observed with natural infections and how sustained any observed inhibitory effects would be. To answer these questions, we used a murine model of physiological microbial exposures through cohousing SPF laboratory mice with pet store mice and examined the acute type 2 response to intranasally delivered fungal allergen extract Alternaria alternata. We found laboratory mice cohoused with pet store mice for two weeks display a suppressed ILC2 response to A. alternata which resulted in reduced eosinophilia. By comparison, mice cohoused for at least two months had ILC2 and eosinophil responses similar to SPF mice despite dramatic changes to the composition of the immune cell populations in the lungs. Lung ILC2 in two-month cohoused mice were still sensitive to subsequent inflammatory cues, as administration of poly(I:C) was able to suppress ILC2 activation and eosinophilia equally well in SPF and two-month cohoused animals. These findings suggest ILC2 dynamically respond to their environment and are not easily desensitized long-term.
Airway Exposure to Polyethyleneimine Nanoparticles Induces Type 2 Immunity by a Mechanism Involving Oxidative Stress and ATP Release
Srisomboon, Yotesawee, Ohkura, Noriyuki , Iijima, Koji, Maniak, Peter J., Kita, Hirohito , O’Grady, Scott M. , Kita, H , Kobayashi, Takao

Mayo Clinic

International Journal of Molecular Sciences | August 23, 2021 | Volume: 22 | Issue: 16 | Pages: 9071

10.3390/ijms22169071 | PMID 34445774 Get It

Polyethyleneimine (PEI) induced immune responses were investigated in human bronchial epithelial (hBE) cells and mice. PEI rapidly induced ATP release from hBE cells and pretreatment with glutathione (GSH) blocked the response. PEI activated two conductive pathways, VDAC-1 and pannexin 1, which completely accounted for ATP efflux across the plasma membrane. Moreover, PEI increased intracellular Ca2+ concentration ([Ca2+]i), which was reduced by the pannexin 1 inhibitor, 10Panx (50 μM), the VDAC-1 inhibitor, DIDS (100 μM), and was nearly abolished by pretreatment with GSH (5 mM). The increase in [Ca2+]i involved Ca2+ uptake through two pathways, one blocked by oxidized ATP (oATP, 300 μM) and another that was blocked by the TRPV-1 antagonist A784168 (100 nM). PEI stimulation also increased IL-33 mRNA expression and protein secretion. In vivo experiments showed that acute (4.5 h) PEI exposure stimulated secretion of Th2 cytokines (IL-5 and IL-13) into bronchoalveolar lavage (BAL) fluid. Conjugation of PEI with ovalbumin also induced eosinophil recruitment and secretion of IL-5 and IL-13 into BAL fluid, which was inhibited in IL-33 receptor (ST2) deficient mice. In conclusion, PEI-induced oxidative stress stimulated type 2 immune responses by activating ATP-dependent Ca2+ uptake leading to IL-33 secretion, similar to allergens derived from Alternaria.
Simvastatin Inhibits Allergen‐induced IL‐33 Secretion in Human Bronchial Epithelial Cells by Blocking ATP Release and Ca 2+ Uptake
Srisomboon, Yotsawee, Maniak, Peter J., Squillace, Diane L., Kita, Hirohito , O’Grady, Scott M.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 33 | Issue: S1 | Pages: No page available

10.1096/fasebj.2019.33.1_supplement.734.5 Get It

Previous studies have demonstrated that simvastatin possesses immunomodulatory effects in airways, but the precise mechanisms and therapeutic potential are poorly understood. The objective of the present study was to investigate the inhibitory effects of simvastatin and b‐methyl‐cyclodextrin (β‐MCD) on the innate immune response of the airway epithelium induced by Alternaria alternata (100 μg/ml) and house dust mite (200 μg/ml, HDM) allergens. Experiments were performed with cultured human bronchial epithelial cells transfected with the human IL‐33 gene to produce a robust and reproducible cell model for the study of IL‐33 secretion. Cells were pretreated with varying concentrations of simvastatin ranging from 0.1 to 10 μM for 24 hours prior to allergen exposure. IL‐33 release was quantified by ELISA (Quantikine ® ) following the procedure provided by the manufacturer. Simvastatin produced a concentration‐dependent inhibition of IL‐33 release that was nearly abolished at 10 μM (IC 50 ; 1.0 μM). In contrast, simvastatin was ineffective at blocking the effects of HDM on IL‐33 release (IC 50 ; >10 μM). Similarly, pretreatment with β‐MCD (5 mM) for 30 minutes also inhibited the Alternaria response, suggesting that depletion of cholesterol from the plasma membrane was responsible for the effects of simvastatin and β‐MCD. Subsequent experiments explored the effects of simvastatin and β‐MCD on Alternaria ‐evoked Ca 2+ uptake, which is necessary for activating IL‐33 release. Simvastatin (10 μM, 24 hrs) and β‐MCD (5 mM; 30 minutes) both abolished the increase in [Ca 2+ ] i induced by Alternaria . We next examined the possibility that abolition of Ca 2+ uptake resulted from inhibition of ATP release, since ATP activates P2X 7 receptors that mediate Ca 2+ influx in response to Alternaria exposure. ATP release was measured in real time using a luciferin/luciferase‐based photon counting assay. Both simvastatin and β‐MCD blocked ATP release. Moreover, addition of 100 μM cholesterol to the extracellular media rescued the effects of simvastatin. These results demonstrated that inhibition of IL‐33 secretion by simvastatin and β‐MCD following Alternaria exposure involved suppression of ATP release that was dependent on membrane cholesterol content. Thus, membrane cholesterol likely plays a pivotal role in innate immune function of airway epithelial cells. Support or Funding Information This study was supported by NIH R01 AI128729 to HK and SMO. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
Substrate‐induced eosinophil adhesion requires intracellular Ca 2+ mobilization and PI‐3 kinase activation.
Bankers‐Fulbright, Jennifer L., Kephart, Gail M., O’Grady, Scott M. , Bartemes, Kathleen R. , Kita, Hirohito

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 21 | Issue: 6 | Pages: No page available

10.1096/fasebj.21.6.a1153 Get It

Aeroallergens Derived from Alternaria alternata Stimulate COX2‐dependent Expression of Antioxidant Defense Enzymes in Human Bronchial Epithelial Cells
Patil, Nandadevi, Maniak, Peter J., Kita, Hirohito , O’Grady, Scott M.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 29 | Issue: S1 | Pages: No page available

10.1096/fasebj.29.1_supplement.1014.2 Get It

Alternaria aeroallergens stimulate allergic inflammation and exacerbation of respiratory distress in patients with asthma. Our previous studies have demonstrated that release of ATP and subsequent increases in intracellular [Ca 2+ ] was the result of Alternaria induced oxidative stress. Stimulation of Human Bronchial Epithelial Cells (HBECs) with Alternaria extract for 12 hours induced the expression of several phase II antioxidant enzymes, including cyclooxygenase 2 (COX2) which exhibited a 19 fold increase in mRNA expression. HBE cells loaded with CellRox™ Orange, a fluorogenic probe used for detecting oxidative stress, revealed that blocking COX2 inhibited resveratrol mediated inhibition of Alternaria induced oxidative stress. Furthermore induction of COX2 following Alternaria exposure was associated with an increase in expression of prostaglandin D 2 synthase and PGD 2 secretion into the extracellular media. Moreover, 15‐deoxy Δ 12,14 ‐protaglandin J 2 (15d‐PGJ 2 ) a metabolic product of PGD 2 was also shown to decrease Alternaria induced oxidative stress. These results suggest that upregulation of COX2 following sustained exposure to Alternaria induces PGD 2 synthesis and subsequent formation of 15d‐PGJ 2 , a known activator of Nrf2 signaling and ultimately, increased expression of phase II antioxidant enzymes.
Alternaria alternata aeroallergens evoke ATP release and IL‐33 secretion from normal and asthmatic bronchial epithelial cells.
Maniak, Peter J., Lancto, Cheryl A., Shivappa, Nandadevi, O’Grady, Scott M. , Kita, Hirohito

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1166.18 Get It

Exposure of human bronchial epithelial (HBE) cells from normal and asthmatic subjects to Alternaria alternata extract evoked rapid and sustained ATP release with greater efficacy observed in cells from asthmatic subjects. Previously, Alternaria aeroallergens were shown to elicit sustained increases in intracellular [Ca 2+ ] i that depended on coordinated activation of P2Y 2 and P2X 7 receptors. In this study, pretreatment with BAPTA‐AM inhibited ATP release, indicating dependency on increases in [Ca 2+ ] i . Alternaria ‐evoked ATP release exhibited a greater peak response and higher EC 50 value in cells obtained from asthmatic subjects compared to normal controls. Furthermore, the maximum increase in [Ca 2+ ] i was greater in cells from asthmatic subjects. The vesicle transport inhibitor brefeldin A blocked Alternaria ‐stimulated incorporation of fluorescent lipid (FM1–43) labeled vesicles into the plasma membrane and ATP release. Additionally, inhibiting vesicular ATP uptake with bafilomycin also blocked ATP release similar to brefeldin A. These results indicated that a primary mechanism for Alternaria ‐induced ATP release involved Ca 2+ ‐dependent vesicular transport. Serine and cysteine protease inhibitors also reduced Alternaria ‐induced ATP release. This result was consistent with our previous data showing that Alternaria ‐evoked increases in [Ca 2+ ] i depend on purinoceptor signaling.
Aeroallergens derived from Alternaria alternata evoke ATP release and chronic increases in intracellular Ca 2+ in bronchial epithelial cells by a mechanism in
Patil, Nandadevi, Maniak, Peter J., Kita, Hirohito , O’Grady, Scott M.

Mayo Clinic

The FASEB Journal | June 15, 2021 | Volume: 28 | Issue: S1 | Pages: No page available

10.1096/fasebj.28.1_supplement.869.4 Get It

Alternaria aeroallergens have been previously shown to stimulate allergic inflammation and exacerbation of respiratory distress in patients with asthma. An early event following exposure to Alternaria extract is the sustained release of ATP and a persistent increase in intracellular [Ca 2+ ] ([Ca 2+ ] i ) resulting from uptake of Ca 2+ ions from the extracellular solution. In the present study we tested the hyopothesis that the release of ATP and the subsequent increase in [Ca 2+ ] i was due to oxidative stress induced by exposure to Alternaria . ATP release following apical stimulation with Alternaria was measured in human primary bronchial epithelial cells using a luciferase/luciferin ATP measurement kit in combination with a modified luminometer that allows for tracking ATP release in real time. Pretreatment with glutathione (GSH) produced a concentration‐dependent inhibition of ATP release with an EC 50 = 500 μM. Furthermore, GSH blocked the increase in [Ca 2+ ] i typically observed following apical exposure to Alternaria. Moreover an increase in the expression of specific antioxidant protein mRNAs was also observed after 12 hours of treatment with Alternaria extract. These proteins included peroxiredoxins 1‐6, keratin 1, cyclooxygenase 2 (COX2) and oxidative stress responsive 1 protein with COX2 having the highest level of expression (~20 fold). These results implicate oxidative stress as an important initiating event in Alternaria evoked airway inflammation. Grant Funding Source : Supported by NIH: HL110539